Ulnar osteosarcoma in dogs: 30 cases (1992–2008)
Authors:
- Ramesh K. SivacolundhuRSRamesh K. Sivacolundhu
- Jeffrey J. RungeJRJeffrey J. Runge
- Taryn A. DonovanTDTaryn A. Donovan
- Lisa G. BarberLBLisa G. Barber
- Corey F. SabaCSCorey F. Saba
- Craig A. CliffordCCCraig A. Clifford
- Louis-Philippe de LorimierLLLouis-Philippe de Lorimier
- Stephen W. AtwaterSAStephen W. Atwater
- Lisa DiBernardiLDLisa DiBernardi
- Kim P. FreemanKFKim P. Freeman
- Philip J. BergmanPBPhilip J. Bergman
- 1 July 2013
- journal article
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 243 (1) , 96-101
Abstract
Objective—To examine the biological behavior of ulnar osteosarcoma and evaluate predictors of survival time in dogs. Design—Retrospective case series. Animals—30 dogs with primary ulnar osteosarcoma. Procedures—Medical records were reviewed. Variables recorded and examined to identify predictors of survival time were signalment, tumor location in the ulna, tumor length, serum alkaline phosphatase activity, surgery type, completeness of excision, tumor stage, tumor grade, histologic subtype, development of metastases, and use of chemotherapy. Results—30 cases were identified from 9 institutions. Eleven dogs were treated with partial ulnar ostectomy and 14 with amputation; in 5 dogs, a resection was not performed. Twenty-two dogs received chemotherapy. Median disease-free interval and survival time were 437 and 463 days, respectively. Negative prognostic factors for survival time determined via univariate analyses were histologic subtype and development of lung metastases. Telangiectatic or telangiectatic-mixed subtype (n = 5) was the only negative prognostic factor identified via multivariate analysis (median survival time, 208 days). Dogs with telangiectatic subtype were 6.99 times as likely to die of the disease. Conclusions and Clinical Relevance—The prognosis for ulnar osteosarcoma in this population was no worse and may have been better than the prognosis for dogs with osteosarcoma involving other appendicular sites. Partial ulnar ostectomy was associated with a low complication rate and good to excellent function and did not compromise survival time. Telangiectatic or telangiectatic-mixed histologic subtype was a negative prognostic factor for survival time. The efficacy of chemotherapy requires further evaluation.Keywords
This publication has 18 references indexed in Scilit:
- Prognostic Factors in the Survival of Patients Diagnosed with Primary Non-Metastatic Osteosarcoma with a Poor Response to Neoadjuvant ChemotherapyClinics, 2009
- Serum vascular endothelial growth factor concentrations and postsurgical outcome in dogs with osteosarcomaVeterinary and Comparative Oncology, 2008
- Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985–2004)Journal of the American Veterinary Medical Association, 2006
- Survival analysis of one versus two treatments of local delivery cisplatin in a biodegradable polymer for canine osteosarcomaVeterinary and Comparative Oncology, 2005
- Use of Alkaline Phosphatase Staining to Differentiate Canine Osteosarcoma from Other Vimentin-positive TumorsVeterinary Pathology, 2005
- Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma IntergroupEuropean Journal of Cancer, 2002
- Prognostic Significance of Serum Alkaline Phosphatase Activity in Canine Appendicular OsteosarcomaJournal of Veterinary Internal Medicine, 2000
- Cisplatin and Doxorubicin Combination Chemotherapy for the Treatment of Canine Osteosarcoma: A Pilot StudyJournal of Veterinary Internal Medicine, 2000
- Prognostic Significance of Serum Alkaline Phosphatase Activity in Canine Appendicular OsteosarcomaJournal of Veterinary Internal Medicine, 2000
- Cisplatin and Doxorubicin Combination Chemotherapy for the Treatment of Canine Osteosarcoma: A Pilot StudyJournal of Veterinary Internal Medicine, 2000